Stiff Person Syndrome and Gluten Sensitivity

Stiff person syndrome (SPS) is a rare autoimmune disease characterised by axial stiffness and episodic painful spasms. It is associated with additional autoimmune diseases and cerebellar ataxia. Most patients with SPS have high levels of glutamic acid decarboxylase (GAD) antibodies. The aetiology of...

Full description

Bibliographic Details
Main Authors: Marios Hadjivassiliou, Panagiotis Zis, David S. Sanders, Nigel Hoggard, Ptolemaios G. Sarrigiannis
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/4/1373
_version_ 1797537082196885504
author Marios Hadjivassiliou
Panagiotis Zis
David S. Sanders
Nigel Hoggard
Ptolemaios G. Sarrigiannis
author_facet Marios Hadjivassiliou
Panagiotis Zis
David S. Sanders
Nigel Hoggard
Ptolemaios G. Sarrigiannis
author_sort Marios Hadjivassiliou
collection DOAJ
description Stiff person syndrome (SPS) is a rare autoimmune disease characterised by axial stiffness and episodic painful spasms. It is associated with additional autoimmune diseases and cerebellar ataxia. Most patients with SPS have high levels of glutamic acid decarboxylase (GAD) antibodies. The aetiology of SPS remains unclear but autoimmunity is thought to play a major part. We have previously demonstrated overlap between anti-GAD ataxia and gluten sensitivity. We have also demonstrated the beneficial effect of a gluten-free diet (GFD) in patients with anti-GAD ataxia. Here, we describe our experience in the management of 20 patients with SPS. The mean age at symptom onset was 52 years. Additional autoimmune diseases were seen in 15/20. Nineteen of the 20 patients had serological evidence of gluten sensitivity and 6 had coeliac disease. Fourteen of the 15 patients who had brain imaging had evidence of cerebellar involvement. Twelve patients improved on GFD and in seven GFD alone was the only treatment required long term. Twelve patients had immunosuppression but only three remained on such medication. Gluten sensitivity plays an important part in the pathogenesis of SPS and GFD is an effective therapeutic intervention.
first_indexed 2024-03-10T12:11:03Z
format Article
id doaj.art-e41f52b582244c228960046e68b14fb0
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T12:11:03Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-e41f52b582244c228960046e68b14fb02023-11-21T16:16:04ZengMDPI AGNutrients2072-66432021-04-01134137310.3390/nu13041373Stiff Person Syndrome and Gluten SensitivityMarios Hadjivassiliou0Panagiotis Zis1David S. Sanders2Nigel Hoggard3Ptolemaios G. Sarrigiannis4Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UKAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UKAcademic Department of Gastroenterology, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UKDepartment of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield S10 2JF, UKAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UKStiff person syndrome (SPS) is a rare autoimmune disease characterised by axial stiffness and episodic painful spasms. It is associated with additional autoimmune diseases and cerebellar ataxia. Most patients with SPS have high levels of glutamic acid decarboxylase (GAD) antibodies. The aetiology of SPS remains unclear but autoimmunity is thought to play a major part. We have previously demonstrated overlap between anti-GAD ataxia and gluten sensitivity. We have also demonstrated the beneficial effect of a gluten-free diet (GFD) in patients with anti-GAD ataxia. Here, we describe our experience in the management of 20 patients with SPS. The mean age at symptom onset was 52 years. Additional autoimmune diseases were seen in 15/20. Nineteen of the 20 patients had serological evidence of gluten sensitivity and 6 had coeliac disease. Fourteen of the 15 patients who had brain imaging had evidence of cerebellar involvement. Twelve patients improved on GFD and in seven GFD alone was the only treatment required long term. Twelve patients had immunosuppression but only three remained on such medication. Gluten sensitivity plays an important part in the pathogenesis of SPS and GFD is an effective therapeutic intervention.https://www.mdpi.com/2072-6643/13/4/1373stiff person syndromeanti-GAD antibodiesgluten sensitivitycoeliac diseasecerebellar ataxiagluten free diet
spellingShingle Marios Hadjivassiliou
Panagiotis Zis
David S. Sanders
Nigel Hoggard
Ptolemaios G. Sarrigiannis
Stiff Person Syndrome and Gluten Sensitivity
Nutrients
stiff person syndrome
anti-GAD antibodies
gluten sensitivity
coeliac disease
cerebellar ataxia
gluten free diet
title Stiff Person Syndrome and Gluten Sensitivity
title_full Stiff Person Syndrome and Gluten Sensitivity
title_fullStr Stiff Person Syndrome and Gluten Sensitivity
title_full_unstemmed Stiff Person Syndrome and Gluten Sensitivity
title_short Stiff Person Syndrome and Gluten Sensitivity
title_sort stiff person syndrome and gluten sensitivity
topic stiff person syndrome
anti-GAD antibodies
gluten sensitivity
coeliac disease
cerebellar ataxia
gluten free diet
url https://www.mdpi.com/2072-6643/13/4/1373
work_keys_str_mv AT marioshadjivassiliou stiffpersonsyndromeandglutensensitivity
AT panagiotiszis stiffpersonsyndromeandglutensensitivity
AT davidssanders stiffpersonsyndromeandglutensensitivity
AT nigelhoggard stiffpersonsyndromeandglutensensitivity
AT ptolemaiosgsarrigiannis stiffpersonsyndromeandglutensensitivity